前列腺MRI的PI-RADS阳性预测值在26个中心间的变异性:腹部放射学会前列腺癌疾病重点专家组的经验
这项回顾性横断面研究纳入26个中心3449例男性(5082个病灶),评估前列腺MRI的PI-RADS对高级别前列腺癌的阳性预测值(PPV);PI-RADS评分≥3的估计PPV为35%(95%CI:27%,43%),≥4为49%(95%CI:40%,58%),各中心间PPV变异较大(四分位距分别为27%-44%和27%-48%)。
要点
- PI-RADS评分≥3时高级别前列腺癌的估计PPV为35%,≥4时为49%。
- 各中心PI-RADS的PPV变异较大,≥3和≥4的四分位距分别为27%-44%和27%-48%。
- 解读PI-RADS评分时需考虑不同中心间阳性预测值的差异。
核心结论
- 前列腺影像报告和数据系统(PI-RADS)的阳性预测值较低,且在不同中心间变异较大。
研究设计与样本
- 回顾性横断面研究,符合HIPAA要求;26个中心(腹部放射学会前列腺癌疾病重点专家组成员)提交数据。
- 纳入疑似或活检证实未治疗的前列腺癌男性,MRI扫描时间为2015年1月至2018年4月,随后行靶向活检。
- 仅纳入至少有一个MRI病灶被赋予PI-RADS评分2-5的男性;采用以机构和个体为随机效应的混合模型逻辑回归估计总体PPV。
诊断标准与关键数值
- 结局为Gleason评分≥3+4(国际泌尿病理学会分级组≥2)的前列腺癌。
- PI-RADS评分≥3的估计PPV为35%(95%CI:27%,43%)。
- PI-RADS评分≥4的估计PPV为49%(95%CI:40%,58%)。
- PI-RADS评分≥3的PPV在中心间的四分位距为27%-44%;PI-RADS评分≥4为27%-48%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background Prostate MRI is used widely in clinical care for guiding tissue sampling, active surveillance, and staging. The Prostate Imaging Reporting and Data System (PI-RADS) helps provide a standardized probabilistic approach for identifying clinically significant prostate cancer. Despite widespread use, the variability in performance of prostate MRI across practices remains unknown. Purpose To estimate the positive predictive value (PPV) of PI-RADS for the detection of high-grade prostate cancer across imaging centers. Materials and Methods This retrospective cross-sectional study was compliant with the HIPAA. Twenty-six centers with members in the Society of Abdominal Radiology Prostate Cancer Disease-focused Panel submitted data from men with suspected or biopsy-proven untreated prostate cancer. MRI scans were obtained between January 2015 and April 2018. This was followed with targeted biopsy. Only men with at least one MRI lesion assigned a PI-RADS score of 2-5 were included. Outcome was prostate cancer with Gleason score (GS) greater than or equal to 3+4 (International Society of Urological Pathology grade group ≥2). A mixed-model logistic regression with institution and individuals as random effects was used to estimate overall PPVs. The variability of observed PPV of PI-RADS across imaging centers was described by using the median and interquartile range. Results The authors evaluated 3449 men (mean age, 65 years ± 8 [standard deviation]) with 5082 lesions. Biopsy results showed 1698 cancers with GS greater than or equal to 3+4 (International Society of Urological Pathology grade group ≥2) in 2082 men. Across all centers, the estimated PPV was 35% (95% confidence interval [CI]: 27%, 43%) for a PI-RADS score greater than or equal to 3 and 49% (95% CI: 40%, 58%) for a PI-RADS score greater than or equal to 4. The interquartile ranges of PPV at these same PI-RADS score thresholds were 27%-44% and 27%-48%, respectively. Conclusion The positive predictive value of the Prostate Imaging and Reporting Data System was low and varied widely across centers. © RSNA, 2020 Online supplemental material is available for this article. See also the editorial by Milot in this issue.
引用
- Westphalen AC, McCulloch CE, Anaokar JM, et al. Variability of the Positive Predictive Value of PI-RADS for Prostate MRI across 26 Centers: Experience of the Society of Abdominal Radiology Prostate Cancer Disease-focused Panel. Radiology. 2020. PMID: 32315265. doi:10.1148/radiol.2020190646
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。